Asahi Intecc Co., Ltd. (AHICF)
USD 16.17
(0.0%)
USD 16.17
(0.0%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 | 39.65 Billion JPY | 3.42% |
| 2023 | 38.34 Billion JPY | 12.78% |
| 2022 | 34 Billion JPY | 51.18% |
| 2021 | 22.49 Billion JPY | 3.38% |
| 2020 | 21.75 Billion JPY | 15.05% |
| 2019 | 18.9 Billion JPY | -0.66% |
| 2018 | 19.03 Billion JPY | 2.4% |
| 2017 | 18.58 Billion JPY | 3.13% |
| 2016 | 18.02 Billion JPY | -2.35% |
| 2015 | 18.45 Billion JPY | 7.12% |
| 2014 | 17.23 Billion JPY | 17.51% |
| 2013 | 14.66 Billion JPY | 16.36% |
| 2012 | 12.6 Billion JPY | 34.31% |
| 2011 | 9.38 Billion JPY | 7.12% |
| 2010 | 8.75 Billion JPY | 3.07% |
| 2009 | 8.49 Billion JPY | 13.49% |
| 2008 | 7.48 Billion JPY | -7.75% |
| 2007 | 8.11 Billion JPY | 47.82% |
| 2006 | 5.49 Billion JPY | 12.33% |
| 2005 | 4.88 Billion JPY | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q1 | 33.54 Billion JPY | -12.51% |
| 2024 Q2 | 30.31 Billion JPY | -9.65% |
| 2024 Q4 | 39.65 Billion JPY | 19.26% |
| 2024 Q3 | 33.25 Billion JPY | 9.7% |
| 2023 Q2 | 34.45 Billion JPY | 6.64% |
| 2023 Q1 | 32.3 Billion JPY | -4.99% |
| 2023 Q3 | 32.99 Billion JPY | -4.22% |
| 2023 Q4 | 38.34 Billion JPY | 16.21% |
| 2023 FY | 38.34 Billion JPY | 12.78% |
| 2022 Q1 | 29.28 Billion JPY | 30.2% |
| 2022 FY | 34 Billion JPY | 51.18% |
| 2022 Q4 | 34 Billion JPY | 11.3% |
| 2022 Q3 | 30.54 Billion JPY | 2.81% |
| 2022 Q2 | 29.71 Billion JPY | 1.47% |
| 2021 Q4 | 22.49 Billion JPY | -1.98% |
| 2021 Q1 | 21.12 Billion JPY | -2.92% |
| 2021 Q3 | 22.94 Billion JPY | 9.73% |
| 2021 Q2 | 20.91 Billion JPY | -0.99% |
| 2021 FY | 22.49 Billion JPY | 3.38% |
| 2020 Q3 | 18.54 Billion JPY | -3.07% |
| 2020 Q1 | 18.18 Billion JPY | -3.81% |
| 2020 Q2 | 19.13 Billion JPY | 5.18% |
| 2020 Q4 | 21.75 Billion JPY | 17.31% |
| 2020 FY | 21.75 Billion JPY | 15.05% |
| 2019 Q2 | 18.3 Billion JPY | -7.43% |
| 2019 FY | 18.9 Billion JPY | -0.66% |
| 2019 Q3 | 18.08 Billion JPY | -1.21% |
| 2019 Q4 | 18.9 Billion JPY | 4.55% |
| 2019 Q1 | 19.77 Billion JPY | 3.9% |
| 2018 FY | 19.03 Billion JPY | 2.4% |
| 2018 Q1 | 17.25 Billion JPY | -7.16% |
| 2018 Q2 | 16.96 Billion JPY | -1.69% |
| 2018 Q3 | 17.79 Billion JPY | 4.89% |
| 2018 Q4 | 19.03 Billion JPY | 6.97% |
| 2017 FY | 18.58 Billion JPY | 3.13% |
| 2017 Q4 | 18.58 Billion JPY | 12.05% |
| 2017 Q3 | 16.58 Billion JPY | -0.57% |
| 2017 Q2 | 16.68 Billion JPY | -0.81% |
| 2017 Q1 | 16.82 Billion JPY | -6.67% |
| 2016 Q1 | 17.04 Billion JPY | -7.67% |
| 2016 Q2 | 15.32 Billion JPY | -10.05% |
| 2016 FY | 18.02 Billion JPY | -2.35% |
| 2016 Q4 | 18.02 Billion JPY | 12.23% |
| 2016 Q3 | 16.05 Billion JPY | 4.76% |
| 2015 Q1 | 16.41 Billion JPY | -4.71% |
| 2015 FY | 18.45 Billion JPY | 7.12% |
| 2015 Q4 | 18.45 Billion JPY | -0.37% |
| 2015 Q3 | 18.52 Billion JPY | 12.57% |
| 2015 Q2 | 16.45 Billion JPY | 0.23% |
| 2014 Q4 | 17.23 Billion JPY | 3.28% |
| 2014 FY | 17.23 Billion JPY | 17.51% |
| 2014 Q3 | 16.68 Billion JPY | 1.0% |
| 2014 Q2 | 16.51 Billion JPY | -1.28% |
| 2014 Q1 | 16.73 Billion JPY | 14.12% |
| 2013 Q1 | 14.09 Billion JPY | 11.83% |
| 2013 FY | 14.66 Billion JPY | 16.36% |
| 2013 Q3 | 14.58 Billion JPY | 4.82% |
| 2013 Q4 | 14.66 Billion JPY | 0.53% |
| 2013 Q2 | 13.91 Billion JPY | -1.25% |
| 2012 Q1 | 9.96 Billion JPY | 6.21% |
| 2012 Q2 | 11.85 Billion JPY | 18.98% |
| 2012 Q3 | 13.24 Billion JPY | 11.74% |
| 2012 Q4 | 12.6 Billion JPY | -4.88% |
| 2012 FY | 12.6 Billion JPY | 34.31% |
| 2011 Q2 | 8.49 Billion JPY | -10.01% |
| 2011 Q3 | 9.48 Billion JPY | 11.7% |
| 2011 FY | 9.38 Billion JPY | 7.12% |
| 2011 Q4 | 9.38 Billion JPY | -1.08% |
| 2011 Q1 | 9.43 Billion JPY | 7.75% |
| 2010 Q3 | 9.2 Billion JPY | 15.36% |
| 2010 Q2 | 7.97 Billion JPY | -0.86% |
| 2010 Q1 | 8.04 Billion JPY | -5.3% |
| 2010 FY | 8.75 Billion JPY | 3.07% |
| 2010 Q4 | 8.75 Billion JPY | -4.83% |
| 2009 FY | 8.49 Billion JPY | 13.49% |
| 2009 Q4 | 8.49 Billion JPY | 1.38% |
| 2009 Q2 | 8.09 Billion JPY | 0.0% |
| 2009 Q3 | 8.38 Billion JPY | 3.52% |
| 2008 FY | 7.48 Billion JPY | -7.75% |
| 2007 FY | 8.11 Billion JPY | 47.82% |
| 2006 FY | 5.49 Billion JPY | 12.33% |
| 2005 FY | 4.88 Billion JPY | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| American Medical Technologies Inc. | 2.34 Million USD | -1687501.39% |
| Ansell Limited | 1.32 Billion USD | -2881.864% |
| Ansell Limited | 1.33 Billion USD | -2876.283% |
| BG Medicine, Inc. | - USD | -Infinity% |
| Biotage AB (publ) | 126.33 Million USD | -31288.876% |
| BioLife Sciences Inc. | - USD | -Infinity% |
| CB Scientific, Inc. | 943.17 Thousand USD | -4204435.334% |
| Psykey, Inc. | 2.47 Million USD | -1602797.957% |
| ConvaTec Group Plc | 2.01 Billion USD | -1864.971% |
| ConvaTec Group Plc | 2.02 Billion USD | -1862.197% |
| Encision Inc. | 1.98 Million USD | -1998722.562% |
| Golden Valley Development, Inc | - USD | -Infinity% |
| Hear AtLast Holdings, Inc. | 3.04 Million USD | -1304168.176% |
| Innovative MedTech Inc. | 6.13 Million USD | -646306.11% |
| LifePoint, Inc. | 2.45 Million USD | -1615762.64% |
| Medite Cancer Diagnostics, Inc. | 10.18 Million USD | -389409.871% |
| Paradigm Medical Industries, Inc. | 3.4 Million USD | -1166252.941% |
| QuantRx Biomedical Corporation | - USD | -Infinity% |
| Remedent, Inc. | 3.04 Million USD | -1304235.099% |
| Reflect Scientific, Inc. | 776.32 Thousand USD | -5108043.583% |
| SmileDirectClub, Inc. | 982.26 Million USD | -3937.216% |
| Sector 10, Inc. | 9.84 Million USD | -402685.943% |
| Shandong Weigao Group Medical Polymer Company Limited | 1.35 Billion USD | -2825.118% |
| SheerVision, Inc. | 1.43 Million USD | -2770328.733% |
| United Health Products, Inc. | 1.99 Million USD | -1983821.908% |
| Vasamed, Inc. | 1 Million USD | -3944593.126% |
| Wearable Health Solutions, Inc. | 3.8 Million USD | -1043400.685% |
| Yubo International Biotech Limited | 2.91 Million USD | -1360814.011% |